Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects.

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Abstract Text:

K Nakamura,S I Yamagishi,T Matsui,H Adachi,M Takeuchi,T Imaizumi,K Nakamura,S I Yamagishi,T Matsui,H Adachi,M Takeuchi,T Imaizumi,K Nakamura,S I Yamagishi,T Matsui,H Adachi,M Takeuchi,T Imaizumi,

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Publishing Authors By Initials

K Nakamura,SI Yamagishi,T Matsui,H Adachi,M Takeuchi,T Imaizumi,K Nakamura,SI Yamagishi,T Matsui,H Adachi,M Takeuchi,T Imaizumi,K Nakamura,SI Yamagishi,T Matsui,H Adachi,M Takeuchi,T Imaizumi,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical and experimental medicine

VOLUME: 7

Page Numbers: 188-90

Journal Abbreviation: Clin. Exp. Med.

ISSN: 1591-8890

DAY: 11

MONTH: 01

YEAR: 2008

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100973405

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects.

AFFILIATION: Nakamura Clinic, Kita-Kyushu, Japan.

Country: Italy

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Exp Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Serum levels of soluble form of receptor for advanced glycation end products sRAGE are correlated with AGEs in both diabetic and non-diabetic subjects Related Publications

• A novel acetyl-CoA carboxylase inhibitor reduces de novo fatty acid synthesis in HepG2 cells and rat primary hepatocytes.
• Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
• Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications.
• Antiatherogenic effect of isoflavones in ovariectomized apolipoprotein e-deficient mice.
• Bilateral pseudocysts of the auricles.
• CORRELATION BETWEEN BRAIN CATECHOLAMINE AND SEDATIVE ACTION OF RESERPINE.
• Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
• Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
• Colorectal polypectomy and risk of colorectal cancer by subsite: the Fukuoka Colorectal Cancer study.
• Detection of coronary artery stenosis after successful percutaneous coronary intervention by dipyridamole stress portable type signal-averaged electrocardiography: a prospective study.
• Effects of milk fermented byLactobacillus gasseri SBT2055 on adipocyte size in rats.
• FKF1 and GIGANTEA complex formation is required for day-length measurement in Arabidopsis.
• Inhibitors of Advanced Glycation End Products (AGEs): Potential Utility for the Treatment of Cardiovascular Disease.
• LXR Agonist Increases the Lymph HDL Transport in Rats by Promoting Reciprocally Intestinal ABCA1 and apo A-I mRNA Levels.
• Lumbosacral subdural hematoma following a ruptured aneurysmal subarachnoid hemorrhage.
• Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
• Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
• Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species.
• Oxidative stress is related to exercise intolerance in patients with heart failure.
• PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
• Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: A possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes.
• Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication.
• Reply to Letter Regarding Article, "Effect of Autologous Bone-marrow Cell Transplantation on Ischemic Ulcer in Patients With Buerger's Disease".
• Serum Level of Advanced Glycation End-Products (AGEs) is an Independent Determinant of Plasminogen Activator Inhibitor-1 (PAI-1) in Nondiabetic General Population.
• Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects.
• The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.
• The properties of ATPase of synaptic vesicle fraction.
• Vitamin C reversed malfunction of peripheral blood-derived mononuclear cells in smokers through antioxidant properties.
• [Internal secretion and hypertension. Catecholamine metabolism and changes in it.]
• [Prognosis and molecular pathogenesis of adult T-cell leukemia/lymphoma]